Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2010
11/10/2010CN101879199A Preparation process of liquidambar formosana parasitism general flavone
11/10/2010CN101879193A Traditional Chinese medicine composite with function of inhibiting alpha-glucuroide and xanthine oxidase and preparation method and applications thereof
11/10/2010CN101879189A Method for producing marasmius androsaceus fermented powder by adopting optimized solid culture medium
11/10/2010CN101879187A Lamina burn and scald plaster for expelling pus and promoting granulation and preparation method thereof
11/10/2010CN101879028A Novel medicine flavor health care pillow and manufacture method thereof
11/10/2010CN101361955B Traditional Chinese medicine combination for treating rheumatism
11/10/2010CN101306112B Baimaiyutong paster
11/10/2010CN101244176B Oral administration medicine for treating traumatic injury and method of preparing the same
11/10/2010CN101234153B Externally-applied medicament for treating bone fracture
11/10/2010CN101204562B External drug for chronic injury, arthritis, join thydrops and pain in shoulder, neck, waist, and leg
11/10/2010CN101204432B Chinese traditional medicine oral liquid preparation for osteoporosis and preparation method thereof
11/10/2010CN101185699B Traditional Chinese medicine decoction for treating cervical spondylosis
11/10/2010CN101108210B Medicine for treating cervical vertebra disease
11/10/2010CN101108192B Phenols glycosides compounds with liveness against osteosporosis
11/10/2010CN101073621B Medicinal composition for treating rheumatic pain
11/10/2010CN101062194B Medicine for treating bone disease and fracture and the preparing method thereof
11/09/2010US7829572 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010CA2488279C Anti-inflammatory compositions derived from chicory
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010127180A2 Dc-stamp antibodies
11/04/2010WO2010126435A1 Novel galactoside inhibitors of galectins
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126094A1 Agent for preventing non-traumatic vertebral fracture in severe osteoporosis patients which comprises eldecalcitol
11/04/2010WO2010126093A1 Agent for preventing forearm bone fracture which comprises eldecalcitol
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010125910A1 Collagen peptide composition having good blood transfer properties, and food and drink containing same
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125271A1 Use of n2o gas for treating chronic pain
11/04/2010WO2010124847A1 Combination therapy comprising mechanical vibration for the treatment of a disease of the musculoskeletal or nervous system
11/04/2010WO2010124655A1 Complex microcapsule comprising epiphyseal plate chondrocytes and preparation method and use thereof
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010124392A1 Methods, compositions, and kits for the treatment of inflammatory conditions
11/04/2010WO2010124391A1 Methods and compositions for improving the health of animals
11/04/2010WO2010124322A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280128 Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280006 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
11/04/2010US20100280002 Aminopyridine-derivatives as inductible no-synthase inhibitors
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279990 Antiproliferative compounds, compositions and methods of use
11/04/2010US20100279986 Heterocyclic derived metalloprotease inhibitors
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278940 Calcium supplements
11/04/2010US20100278935 Immune System Modulator Formulation
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278902 Strontium doped bioactive glasses
11/04/2010US20100278891 Bi-phasic compressed porous reinforcement materials suitable for implant
11/04/2010US20100278881 Use of calcitonin in osteoarthritis
11/04/2010US20100278877 Body tissue filling material and method for production thereof
11/04/2010US20100278840 Methods for treating rheumatoid arthritis using il-17 antagonists
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278806 Composition Containing Arazyme for the Prevention and Treatment of Arthritis
11/04/2010CA2771204A1 Methods and compositions for improving the health of animals
11/04/2010CA2760589A1 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2760330A1 Dc-stamp antibodies
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010CA2759424A1 Collagen peptide composition having good ability to enter the blood and food or beverage containing the same
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010CA2755780A1 Use of n2o gas for treating chronic pain
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246061A1 Brachystemma calycinum extract for osteoarthritis
11/03/2010EP2246050A1 Combination therapy comprising mechanical vibration for the treatment of a disease of the musculoskeletal or nervous system
11/03/2010EP2245062A1 Methods of treating bone-loss disorders using a gm-csf antagonist
11/03/2010EP2244727A1 A method for restoring bmp-receptor signaling in a cell
11/03/2010EP1957088B1 Viscosupplementation with algal polysaccharides in the treatment of arthritis
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1242437B1 Novel stromelysin inhibitors
1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 820